News
Honeywell and Recipharm to speed development of inhalers with a near – zero global warming potential propellant
Honeywell and global contract development and manufacturing organization (CDMO) Recipharm have announced a commercial partnership that will speed the development of pressurized metered dose inhalers...
BioPharma
Overcoming Challenges In Biopharma Novel Drug Manufacturing
The biopharmaceutical sector is undergoing a significant transformation in treating complex diseases, especially in oncology, driven by innovative drug approaches. This shift entails personalized therapies,...
Drug Research
Unlocking Value-Based Pricing Strategies In Pharma CDMOs
Contract Development and Manufacturing Organizations (CDMOs), which pharmaceutical companies increasingly delegate product development and manufacturing, operate in a fragmented market undergoing substantial consolidation. Yet, many...
News
Global Vaccine Production Drives Pharmaceutical CDMO Market
According to insights, the pharmaceutical CDMO market is projected to grow at a Compound Annual Growth Rate (CAGR) of 7.29% until 2028. This growth could...
Drug Research
Small Molecule Innovator CDMO Market Poised For Huge Growth
The projected worth of the Global Small Molecule Innovator CDMO Market is anticipated to surpass $76.50 billion by 2031, displaying a compounded annual growth rate...
Drug Research
Parexel, Partex Partner to Accelerate Drug Discovery and Development
Parexel, a CRO providing a full range of Phase I to IV clinical development services, and Partex, a digital pharma platform, entered a strategic alliance...
Drug Research
AGC Biologics, Asahi Kasei Enter Clinical Drug Substance Agreement
AGC Biologics, a global biopharmaceutical CDMO, entered a new agreement with Asahi Kasei Pharma to produce clinical drug substance for antibody-based therapies at AGC Biologics’...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.